1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 29
1.3 SCOPE OF THE STUDY 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED FOR THE STUDY 31
1.4 CURRENCY 31
1.5 LIMITATIONS 32
1.6 STAKEHOLDERS 32

2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.1.1 SECONDARY SOURCES 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY SOURCES 35
2.1.2.1 primary sources 36
2.1.2.2 key data from primary sources 37
2.2 MARKET SIZE ESTIMATION 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41
2.4 MARKET SHARE ESTIMATION 42
2.5 ASSUMPTIONS FOR THE STUDY 42

3 EXECUTIVE SUMMARY 43

4 PREMIUM INSIGHTS 47
4.1 COMPANION ANIMAL DIAGNOSTICS: MARKET OVERVIEW 47
4.2 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, 2018 48
4.3 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC MIX 50
4.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 50

5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 51
5.3 KEY MARKET DRIVERS 52
5.3.1 GROWTH IN THE COMPANION ANIMAL POPULATION 52
5.3.2 RISING DEMAND FOR PET INSURANCE 53
5.3.3 INCREASING NUMBER OF VETERINARY PRACTITIONERS IN DEVELOPED ECONOMIES 54
5.4 KEY MARKET RESTRAINTS 55
5.4.1 RISING PET CARE COSTS 55
5.5 KEY MARKET OPPORTUNITIES 55
5.5.1 GROWING DEMAND FOR RAPID TESTS & PORTABLE INSTRUMENTS FOR POINT-OF-CARE (POC) DIAGNOSTIC SERVICES 55
5.5.2 USE OF ADVANCED TECHNOLOGIES TO IMPROVE DISEASE DIAGNOSIS ACCURACY IN COMPANION ANIMALS 56
5.6 KEY CHALLENGES 56
5.6.1 LACK OF ANIMAL HEALTHCARE AWARENESS IN EMERGING MARKETS 56
5.6.2 SHORTAGE OF VETERINARIANS IN EMERGING MARKETS 56

6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY 58
6.1 INTRODUCTION 59
6.2 IMMUNODIAGNOSTICS 59
6.2.1 LATERAL FLOW ASSAYS 62
6.2.1.1 Rapid tests 63
6.2.1.1.1 Rising prevalence of infectious diseases to drive the adoption of lateral flow rapid tests 63
6.2.1.2 Strip readers 64
6.2.1.2.1 Lateral flow strip readers are not frequently used by veterinary practitioners 64
6.2.2 ELISA TESTS 65
6.2.2.1 ELISA tests segment to register the highest growth rate during the forecast period 65
6.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 66
6.2.3.1 Growing number of allergy cases in pets to drive market growth 66
6.2.4 IMMUNOASSAY ANALYZERS 67
6.2.4.1 A large number of samples can be loaded into immunoassay analyzers to determine the results of immunoassay tests 67
6.2.5 OTHER IMMUNODIAGNOSTIC PRODUCTS 68
6.3 CLINICAL BIOCHEMISTRY 69
6.3.1 CLINICAL CHEMISTRY ANALYSIS 71
6.3.1.1 Reagents, clips, and cartridges 73
6.3.1.2 Analyzers 74
6.3.1.2.1 Clinical chemistry analyzers have wide applications in veterinary clinics & hospitals, reference laboratories, and research institutes 74
6.3.2 GLUCOSE MONITORING 75
6.3.2.1 Blood glucose strips 76
6.3.2.1.1 Blood glucose strips segment accounted for the largest share of the glucose monitoring market in 2019 76
6.3.2.2 Glucose monitors 77
6.3.2.2.1 The use of glucose monitors helps in making diagnostic and therapeutic decisions in a relatively affordable manner 77
6.3.2.3 Urine glucose strips 78
6.3.2.3.1 Urine glucose strips are used to measure glucose and ketone concentration in urine 78
6.3.3 BLOOD GAS ELECTROLYTE ANALYSIS 79
6.3.3.1 Reagents, clips, and cartridges 81
6.3.3.1.1 Leading market players are providing various cartridges specific for cats, dogs, and equine to measure multiple electrolytes 81
6.3.3.2 Analyzers 82
6.3.3.2.1 Blood gas electrolyte analyzers are used to determine blood pH and the amount of oxygen and carbon dioxide in the blood 82
6.4 HEMATOLOGY 83
6.4.1 CARTRIDGES 84
6.4.1.1 Hematology cartridges are used to measure the hematocrit and hemoglobin levels in animal blood samples 84
6.4.2 ANALYZERS 85
6.4.2.1 Hematology analyzers are used to measure blood cell count and the coagulation time of blood 85
6.5 URINALYSIS 86
6.5.1 CLIPS & CARTRIDGES/PANELS 88
6.5.1.1 Clips and cartridges/panels are used to measure multiple electrolytes and metabolites for the detection of kidney diseases and urinary tract infections 88
6.5.2 URINE ANALYZERS 89
6.5.2.1 Technological advancements to support the growth of this market segment 89
6.5.3 URINE TEST STRIPS 90
6.5.3.1 Urine test strips are used for the qualitative evaluation of urine parameters 90
6.6 MOLECULAR DIAGNOSTICS 91
6.6.1 POLYMERASE CHAIN REACTION TESTS 93
6.6.1.1 PCR testing is a significant tool for the early diagnosis of diseases in dogs, cats, and other companion animals 93
6.6.2 MICROARRAYS 94
6.6.2.1 Increased speed and accuracy of screening and confirmation are driving the use of microarrays in the diagnosis of various conditions in companion animals 94
6.6.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 95
6.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES 96

7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION 97
7.1 INTRODUCTION 98
7.2 CLINICAL PATHOLOGY 98
7.2.1 CLINICAL PATHOLOGY IS THE LARGEST APPLICATION SEGMENT IN THE COMPANION ANIMAL DIAGNOSTICS MARKET 98
7.3 BACTERIOLOGY 99
7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 99
7.4 VIROLOGY 100
7.4.1 RISING NUMBER OF VIRAL OUTBREAKS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 100
7.5 PARASITOLOGY 101
7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 101
7.6 OTHER APPLICATIONS 102

8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE 104
8.1 INTRODUCTION 105
8.2 DOGS 106
8.2.1 RISING PET DOG POPULATION TO DRIVE MARKET GROWTH 106
8.3 CATS 107
8.3.1 GROWING RESEARCH INTO FELINE HEALTHCARE AND WELLBEING SUPPORTS MARKET GROWTH 107
8.4 HORSES 109
8.4.1 GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH 109
8.5 OTHER COMPANION ANIMALS 110

9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER 112
9.1 INTRODUCTION 113
9.2 DIAGNOSTIC LABORATORIES 114
9.2.1 DIAGNOSTIC LABORATORIES RECEIVE A LARGE VOLUME OF SAMPLES FROM VETERINARY PRACTICES 114
9.3 VETERINARY HOSPITALS & CLINICS 115
9.3.1 HOSPITALS & CLINICS ARE THE FIRST POINTS OF CONTACT FOR PET OWNERS 115
9.3.2 HOME-CARE SETTINGS 116
9.3.3 IMPROVED CARE AND COST CONTROL DRIVES THE ADOPTION OF POC DIAGNOSTICS WITHIN HOME CARE SETTINGS 116
9.4 RESEARCH INSTITUTES & UNIVERSITIES 117
9.4.1 THE NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS HAVE INCREASED IN RECENT YEARS 117

10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION 119
10.1 INTRODUCTION 120
10.2 NORTH AMERICA 121
10.2.1 US 127
10.2.1.1 The US dominates the companion animal diagnostics market in North America 127
10.2.2 CANADA 131
10.2.2.1 Awareness of pet health has risen in Canada 131
10.3 EUROPE 136
10.3.1 GERMANY 142
10.3.1.1 Germany is the largest market for companion animal diagnostics in Europe 142
10.3.2 UK 148
10.3.2.1 Stable increase in pet ownership and preventive measures against animal diseases promoted by regulatory authorities to drive the UK market 148
10.3.3 FRANCE 153
10.3.3.1 Technological expertise and innovations attract market players to compete in the companion animal diagnostics market in France 153
10.3.4 ITALY 158
10.3.4.1 Increased pet adoption, along with better availability of pet products through large-scale outlets, supports market growth in Italy 158
10.3.5 SPAIN 162
10.3.5.1 Rising animal health expenditure and the growing number of veterinary facilities to drive the growth of this market 162
10.3.6 BENELUX 166
10.3.7 REST OF EUROPE 171
10.4 ASIA PACIFIC 175
10.4.1 CHINA 181
10.4.1.1 China dominates the Asia Pacific companion animal diagnostics market 181
10.4.2 JAPAN 185
10.4.2.1 Rising demand for imported pet breeds is expected to drive the overall growth of this market 185
10.4.3 INDIA 189
10.4.3.1 India is an untapped market with large growth potential in companion animal diagnostics 189
10.4.4 AUSTRALIA 193
10.4.5 REST OF APAC 198
10.5 LATIN AMERICA 201
10.5.1 BRAZIL 206
10.5.1.1 Brazil has the third-largest pet population in the world 206
10.5.2 MEXICO 210
10.5.2.1 Mexico is the second-largest pet care market in Latin America 210
10.5.3 REST OF LATIN AMERICA 214
10.6 MIDDLE EAST 219
10.6.1 RELUCTANCE TO SPEND ON PET HEALTH HAS SLOWED THE PACE OF MARKET GROWTH 219
10.7 AFRICA 223
10.7.1 DISEASES IN IMPORTED BREEDS TO DRIVE THE GROWTH OF THE MARKET 223

11 COMPETITIVE LANDSCAPE 228
11.1 INTRODUCTION 228
11.2 GROWTH STRATEGY MATRIX 229
11.3 MARKET SHARE ANALYSIS 229
11.4 COMPETITIVE SITUATION AND TRENDS 230
11.4.1 PRODUCT LAUNCHES 230
11.4.2 ACQUISITIONS 231
11.4.3 PARTNERSHIPS 232
11.4.4 EXPANSIONS 232
11.5 COMPETITIVE LEADERSHIP MAPPING 233
11.5.1 VISIONARY LEADERS 233
11.5.2 INNOVATORS 233
11.5.3 DYNAMIC DIFFERENTIATORS 233
11.5.4 EMERGING COMPANIES 234

12 COMPANY PROFILES 235
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 IDEXX LABORATORIES, INC. 235
12.2 ZOETIS INC. 239
12.3 HESKA CORPORATION 243
12.4 THERMO FISHER SCIENTIFIC INC. 247
12.5 VIRBAC 250
12.6 NEOGEN CORPORATION 253
12.7 BIOMÉRIEUX SA 255
12.8 INDICAL BIOSCIENCE GMBH (QIAGEN N.V.) 257
12.9 FUJIFILM HOLDINGS CORPORATION 259
12.10 IDVET 261
12.11 RANDOX LABORATORIES, LTD. 262
12.12 MINDRAY MEDICAL INTERNATIONAL LIMITED (A PART OF EXCELSIOR UNION LIMITED) 264
12.13 SKYLA 265
12.14 BIONOTE INC. 266
12.15 SCIL ANIMAL CARE COMPANY GMBH 268
12.16 OTHER EMERGING PLAYERS 269
12.16.1 URIT MEDICAL ELECTRONIC CO., LTD. 269
12.16.2 EUROLYSER DIAGNOSTICA GMBH 269
12.16.3 NOVA BIOMEDICAL 270
12.16.4 FASSISI GMBH 271
12.16.5 SWISSAVANS AG 272
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies

13 APPENDIX 273
13.1 INSIGHTS OF INDUSTRY EXPERTS 273
13.2 DISCUSSION GUIDE 274
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 281
13.4 AVAILABLE CUSTOMIZATIONS 283
13.5 RELATED REPORTS 283
13.6 AUTHOR DETAILS 284

LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES 31
TABLE 2 LIST OF STAKEHOLDERS INTERVIEWED FOR THE STUDY 36
TABLE 3 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2016) (USD MILLION) 54
TABLE 4 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 59
TABLE 5 LIST OF KEY COMPANION ANIMAL IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET 60
TABLE 6 IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 61
TABLE 7 IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 8 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 62
TABLE 9 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 10 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 64
TABLE 11 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 65
TABLE 12 ELISA TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 13 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 67
TABLE 14 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 68
TABLE 15 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 69
TABLE 16 CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 70
TABLE 17 CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 18 LIST OF KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE IN THE MARKET 71
TABLE 19 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 72
TABLE 20 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 72
TABLE 21 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 73
TABLE 22 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 74
TABLE 23 LIST OF KEY GLUCOSE MONITORING PRODUCTS AVAILABLE IN THE MARKET 75
TABLE 24 GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 75
TABLE 25 GLUCOSE MONITORING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 26 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 27 GLUCOSE MONITORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 28 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 79
TABLE 29 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 80
TABLE 30 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 31 BLOOD GAS ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 81
TABLE 32 BLOOD GAS ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 33 KEY HEMATOLOGY PRODUCTS AVAILABLE IN THE MARKET 83
TABLE 34 HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 83
TABLE 35 HEMATOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 84
TABLE 36 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 85
TABLE 37 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 86
TABLE 38 LIST OF KEY URINALYSIS PRODUCTS AVAILABLE IN THE MARKET 87
TABLE 39 URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 87
TABLE 40 URINALYSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 41 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 89
TABLE 42 URINE ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 90
TABLE 43 URINE TEST STRIPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 91
TABLE 44 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 92
TABLE 45 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 92
TABLE 46 PCR TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 47 MICROARRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 94
TABLE 48 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 95
TABLE 49 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 50 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 98
TABLE 51 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 99
TABLE 52 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 100
TABLE 53 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 101
TABLE 54 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 102
TABLE 55 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 103
TABLE 56 COMPANION ANIMAL POPULATION, BY COUNTRY, 2014–2017 (MILLION) 106
TABLE 57 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 106
TABLE 58 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2018–2025 (USD MILLION) 107
TABLE 59 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2018–2025 (USD MILLION) 108
TABLE 60 HORSE POPULATION, BY REGION, 2014–2017 (MILLION) 109
TABLE 61 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2018–2025 (USD MILLION) 110
TABLE 62 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 63 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION) 113
TABLE 64 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, 2018-2025 (USD MILLION) 114
TABLE 65 VETERINARY VISIT EXPENSES FOR CATS AND DOGS IN THE US 115
TABLE 66 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS AND CLINICS, 2018-2025 (USD MILLION) 116
TABLE 67 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME-CARE SETTINGS, 2018-2025 (USD MILLION) 117
TABLE 68 COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES AND UNIVERSITIES, 2018-2025 (USD MILLION) 118
TABLE 69 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2018–2025 (USD MILLION) 120
TABLE 70 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 123
TABLE 71 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 123
TABLE 72 NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 123
TABLE 73 NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 124
TABLE 74 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 124
TABLE 75 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 124
TABLE 76 NORTH AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 124
TABLE 77 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 125
TABLE 78 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 125
TABLE 79 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 125
TABLE 80 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 126
TABLE 81 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 126
TABLE 82 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 126
TABLE 83 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2016 VS. 2018 127
TABLE 84 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 128
TABLE 85 US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 128
TABLE 86 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 128
TABLE 87 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 129
TABLE 88 US: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 129
TABLE 89 US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 129
TABLE 90 US: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 129
TABLE 91 US: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 130
TABLE 92 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 130
TABLE 93 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 130
TABLE 94 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 131
TABLE 95 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 131
TABLE 96 COMPANION ANIMAL POPULATION IN CANADA, 2014 VS. 2016 (MILLION) 132
TABLE 97 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 132
TABLE 98 CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 99 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 133
TABLE 100 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 133
TABLE 101 CANADA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 133
TABLE 102 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 134
TABLE 103 CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 134
TABLE 104 CANADA: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 134
TABLE 105 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 135
TABLE 106 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 135
TABLE 107 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 135
TABLE 108 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 136
TABLE 109 EUROPE: NUMBER OF VETERINARIANS, 2012–2018 138
TABLE 110 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 138
TABLE 111 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 139
TABLE 112 EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 113 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 139
TABLE 114 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 140
TABLE 115 EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 140
TABLE 116 EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 140
TABLE 117 EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 140
TABLE 118 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 141
TABLE 119 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 141
TABLE 120 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 141
TABLE 121 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 142
TABLE 122 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 142
TABLE 123 GERMANY: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION) 143
TABLE 124 GERMANY: NUMBER OF VETERINARIANS, 2016 VS. 2018 143
TABLE 125 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 144
TABLE 126 GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 144
TABLE 127 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 144
TABLE 128 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 145
TABLE 129 GERMANY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 145
TABLE 130 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 145
TABLE 131 GERMANY: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 146
TABLE 132 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 146
TABLE 133 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 146
TABLE 134 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 147
TABLE 135 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 147
TABLE 136 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 147
TABLE 137 UK: COMPANION ANIMAL POPULATION (2010–2018) (MILLION) 148
TABLE 138 UK: NUMBER OF VETERINARIANS, 2014 VS. 2017 149
TABLE 139 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 149
TABLE 140 UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 141 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 150
TABLE 142 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 150
TABLE 143 UK: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 150
TABLE 144 UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 151
TABLE 145 UK: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 151
TABLE 146 UK: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 151
TABLE 147 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 152
TABLE 148 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 152
TABLE 149 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 152
TABLE 150 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 153
TABLE 151 FRANCE: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION) 153
TABLE 152 FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2017 154
TABLE 153 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 154
TABLE 154 FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 154
TABLE 155 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 155
TABLE 156 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 155
TABLE 157 FRANCE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 155
TABLE 158 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 156
TABLE 159 FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 156
TABLE 160 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 156
TABLE 161 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 157
TABLE 162 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 157
TABLE 163 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 157
TABLE 164 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 158
TABLE 165 ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2016 158
TABLE 166 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 159
TABLE 167 ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 159
TABLE 168 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 159
TABLE 169 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 160
TABLE 170 ITALY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 160
TABLE 171 ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 160
TABLE 172 ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 161
TABLE 173 ITALY: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 161
TABLE 174 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 161
TABLE 175 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 161
TABLE 176 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 162
TABLE 177 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 162
TABLE 178 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 163
TABLE 179 SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 163
TABLE 180 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 163
TABLE 181 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 164
TABLE 182 SPAIN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 164
TABLE 183 SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 164
TABLE 184 SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 165
TABLE 185 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 165
TABLE 186 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 165
TABLE 187 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 165
TABLE 188 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 166
TABLE 189 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 166
TABLE 190 COMPANION ANIMAL POPULATION IN BENELUX, 2018 (USD MILLION) 167
TABLE 191 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 167
TABLE 192 BENELUX: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 167
TABLE 193 BENELUX: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 168
TABLE 194 BENELUX: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 168
TABLE 195 BENELUX: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 168
TABLE 196 BENELUX: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 169
TABLE 197 BENELUX: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 169
TABLE 198 BENELUX: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 169
TABLE 199 BENELUX: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 170
TABLE 200 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 170
TABLE 201 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 170
TABLE 202 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 171
TABLE 203 COMPANION ANIMAL POPULATION IN THE REST OF EUROPE, 2018 (MILLION) 171
TABLE 204 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016) 172
TABLE 205 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 172
TABLE 206 ROE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 207 ROE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 173
TABLE 208 ROE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 173
TABLE 209 ROE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 173
TABLE 210 ROE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 173
TABLE 211 ROE: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 174
TABLE 212 ROE: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 174
TABLE 213 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 174
TABLE 214 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 174
TABLE 215 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 175
TABLE 216 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 175
TABLE 217 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 177
TABLE 218 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 177
TABLE 219 APAC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 177
TABLE 220 APAC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 178
TABLE 221 APAC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 178
TABLE 222 APAC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 178
TABLE 223 APAC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 179
TABLE 224 APAC: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 179
TABLE 225 APAC: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 179
TABLE 226 APAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 179
TABLE 227 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 180
TABLE 228 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 180
TABLE 229 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 180
TABLE 230 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 181
TABLE 231 CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 181
TABLE 232 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 182
TABLE 233 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 182
TABLE 234 CHINA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 182
TABLE 235 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 183
TABLE 236 CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 183
TABLE 237 CHINA: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 183
TABLE 238 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 183
TABLE 239 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD 184
TABLE 240 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 184
TABLE 241 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 184
TABLE 242 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 185
TABLE 243 JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 185
TABLE 244 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 186
TABLE 245 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 186
TABLE 246 JAPAN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 186
TABLE 247 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 187
TABLE 248 JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 187
TABLE 249 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 187
TABLE 250 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 188
TABLE 251 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2018–2025 (USD MILLION) 188
TABLE 252 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 188
TABLE 253 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 189
TABLE 254 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 190
TABLE 255 INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2018–2025 (USD MILLION) 190
TABLE 256 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 190
TABLE 257 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 191
TABLE 258 INDIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 191
TABLE 259 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 191
TABLE 260 INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 192

Please contact our Customer Support Center to get the complete Table of Contents